Off-campus WMU users: To download campus access articles, please use the following link to log in with your WMU ID and password: log in to proxy server

Authors

Carolyn Gotay

Document Type

Article Restricted

Publication Date

11-2015

Journal Title

The Lancet Oncology

Volume Number

16

Issue Number

15

First Page

1445

Last Page

1446

Abstract

Patient-reported outcomes, including quality of life and symptom reports, have contributed to cancer care and research in many ways, including improved prognostication of how long patients with cancer will live. In The Lancet Oncology, Fabio Efficace and colleagues provide some of the first evidence that patient-reported outcomes from patients with intermediate-2-risk and high-risk myelodysplastic syndromes—specifically their ratings of fatigue—are a powerful indicator for their length of survival.

Share

COinS